Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 4/20 | 0.45 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.35 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.30 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.30 |
| ▸ | ITGAL | P20701 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5015667 | 0.80 | HTT (0.41) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL10275020 | 0.80 | HTT (0.49) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL28938060 | 0.80 | HTT (0.41) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL2367517 | 0.80 | TSHR (0.47) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL25402123 | 0.77 | HTT (0.46) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL28189973 | 0.77 | TSHR (0.49) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL182767 | 0.76 | HTT (0.39) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL723215 | 0.76 | HTT (0.39) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL23091412 | 0.74 | HTT (0.48) | HTTBAZ2BTSHRHPGDNCOA1 | |
| SCHEMBL20954695 | 0.73 | HTT (0.47) | HTTBAZ2BTSHRHPGDNCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4021909-A1 | BIOFUNCTIONAL THIOPHENE MONOMERS | Martin, David C. (US) | 2022-07-06 | — | — | EP | disclosed |
| WO-2021041874-A1 | BIOFUNCTIONAL THIOPHENE MONOMERS | MARTIN DAVID C (US) | 2021-03-04 | — | — | WO | disclosed |
| EP-1841773-B1 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OF MAKING THEM, AND USE THEREOF | DU PONT (US) | 2012-06-27 | — | — | EP | disclosed |
| US-7999121-B2 | Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-08-16 | — | — | US | disclosed |
| US-20110024693-A1 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OFMAKING THEM, AND USE THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-02-03 | — | — | US | disclosed |
| US-7838688-B2 | dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-23 | — | — | US | disclosed |
| EP-1841773-A4 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OF MAKING THEM, AND USE THEREOF | DU PONT (US) | 2009-05-13 | — | — | EP | disclosed |
| US-20090008609-A1 | dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-01-08 | — | — | US | disclosed |
| EP-1841773-A2 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OF MAKING THEM, AND USE THEREOF | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-10-10 | — | — | EP | disclosed |
| WO-2006073968-A2 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OF MAKING THEM, AND USE THEREOF | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110024693-A1 | DERIVATIZED 3,4-ALKYLENEDIOXYTHIOPHENE MONOMERS, METHODS OFMAKING THEM, AND USE THEREOF | AS3MT, TET3, TET2 | HTT 466/4885BAZ2B 2598/4885TSHR 4693/4885 |
| US-20090008609-A1 | dehalogenation and hydrolysis to form a water soluble polythiophene monomer; PEDOT electroconductive polymers | HPD, HAAO, DDT | HTT 409/4885BAZ2B 3253/4885TSHR 3587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.